Although not as crucial as the loss of other DNA damage checkpoint proteins such as 53BP1 and Rev7, reduction of KDM3C disrupts the balance between the two DNA repair pathways, breaching the anti-cancer barrier of prostate cells. Here, JMJD1C is linked to cancer.